Mark Quinlivan

Modeling Varicella Zoster Virus Persistence and Reactivation – Closer to Resolving a Perplexing Persistent State

Evolution and world-wide distribution of varicella–zoster virus clades

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

Macrophages in immunoregulation and therapeutics

Predicting and preventing post‐herpetic neuralgia: Are current risk factors useful in clinical practice?

Chickenpox

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005–2012

Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2

Varicella zoster virus infection

The burden of Herpes Zoster: A prospective population based study

Different genotype pattern of varicella‐zoster virus obtained from patients with varicella and zoster in Germany

Zoster Vaccine: Current Status and Future Prospects

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review

Systematic review of incidence and complications of herpes zoster: towards a global perspective

The epidemiology of glioma in adults: a "state of the science" review

Interaction of allergy history and antibodies to specific varicella‐zoster virus proteins on glioma risk

Neuropathic Pain: From Mechanisms to Treatment

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Global Identification of Three Major Genotypes of Varicella-Zoster Virus: Longitudinal Clustering and Strategies for Genotyping

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

Anti-cytokine autoantibodies in postherpetic neuralgia

Molecular studies of Varicella zoster virus

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella‐zoster virus

A case of varicella caused by co-infection with two different genotypes of varicella–zoster virus

Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration*

Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?

Varicella‐Zoster–Virus Genotypes in East London: A Prospective Study in Patients with Herpes Zoster

Safety profile of live varicella virus vaccine (Oka/Merck): Five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)

The Molecular Epidemiology of Varicella‐Zoster Virus: Evidence for Geographic Segregation

Clinical and molecular aspects of the live attenuated Oka varicella vaccine

Vaccine Oka Varicella‐Zoster Virus Genotypes Are Monomorphic in Single Vesicles and Polymorphic in Respiratory Tract Secretions

Genotyping of Varicella-Zoster Virus and the Discrimination of Oka Vaccine Strains by TaqMan Real-Time PCR